Darolutamide is a medication used in the treatment of prostate cancer. It is important to be aware of the potential side effects associated with this drug, particularly those related to the gastrointestinal system. The sources you provided offer valuable information on this topic.

According to the Drug Patent Watch website, the common gastrointestinal side effects of darolutamide include nausea, diarrhea, and decreased appetite [1]. These side effects are also mentioned on the Drugs.com website, which further adds that abdominal pain and vomiting may occur as well [2].

A study published in the National Center for Biotechnology Information (NCBI) also highlights gastrointestinal side effects associated with darolutamide. The study reports that diarrhea is the most common adverse event related to this medication, occurring in approximately 13% of patients [3].

It is important to note that while these sources provide information on common gastrointestinal side effects of darolutamide, individual experiences may vary. It is recommended to consult with a healthcare professional for personalized advice and guidance regarding potential side effects and management strategies.

In summary, the common gastrointestinal side effects of darolutamide include nausea, diarrhea, decreased appetite, abdominal pain, and vomiting. These side effects may occur in a subset of patients and it is advisable to consult a healthcare professional for personalized advice.

Sources:
[1] Drug Patent Watch. (n.d.). Darolutamide. Retrieved from https://www.drugpatentwatch.com/p/tradename/DAROLUTAMIDE
[2] Drugs.com. (n.d.). Darolutamide Side Effects. Retrieved from https://www.drugs.com/sfx/darolutamide-side-effects.html
[3] Tran, C., Oudard, S., Roca, E., Loriot, Y., & Fizazi, K. (2020). Current developments of darolutamide in prostate cancer: an up-to-date review of its safety, efficacy, and clinical potential. Therapeutic Advances in Medical Oncology, 12, 1-14. doi: 10.1177/1758835920902485